Evidence map›Paper›PMID 29494150›Full record

ArticleJournal of proteome research2018

Circulating Microvesicles from Pancreatic Cancer Accelerate the Migration and Proliferation of PANC-1 Cells.

Mingrui An, Jianhui Zhu, Jing Wu, Kyle C Cuneo, David M Lubman

Abstract read
In one paragraph

Article in Journal of proteome research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Exosome Mediated Cancer Therapeutic Approach:Present Status and Future Prospectives.Asian Pacific journal of cancer prevention : APJCP · 2023
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mingrui AnDepartment of Surgery , University of Michigan Medical Center , Ann Arbor , Michigan 48109 , United States.
Jianhui ZhuDepartment of Surgery , University of Michigan Medical Center , Ann Arbor , Michigan 48109 , United States.
Jing WuDepartment of Surgery , University of Michigan Medical Center , Ann Arbor , Michigan 48109 , United States.
Kyle C CuneoDepartment of Radiation Oncology , University of Michigan , Ann Arbor , Michigan 48109 , United States.
David M LubmanDepartment of Surgery , University of Michigan Medical Center , Ann Arbor , Michigan 48109 , United States.ORCID 0000-0001-7731-0232
University of Michigan · US

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI Julie Lynn Boerner · 1985 to 2026
$68.4M
Translational Research in GI CancerP50CA130810 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BRENNER, DEAN E. · 2010 to 2016
$11.8M
Pilot Project ProgramP30ES020957 · NIEHS · WAYNE STATE UNIVERSITY · PI RUDEN, DOUGLAS M · 2014 to 2021
$10.1M
Microsequencing in an Ion Trap/reTOF DeviceR01GM049500 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUBMAN, DAVID M. · 1994 to 2016
$3.0M
Orbitrap Velos with ETD for Wayne State ProteomicsS10OD010700 · OD · WAYNE STATE UNIVERSITY · PI STEMMER, PAUL M · 2012 to 2012
$575k
Therapeutic Monitoring in Pancreatic Cancer Using an Exosome Based Mass Spec AssayR21CA189775 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUBMAN, DAVID M. · 2015 to 2016
$371k
NCI NIH HHS P30 CA022453NCI NIH HHS P50 CA130810NCI NIH HHS R21 CA189775NIEHS NIH HHS P30 ES020957NIGMS NIH HHS R01 GM049500NIH HHS S10 OD010700
6 · The paper itself

Abstract

Circulating microvesicles are able to mediate long-distance cell-cell communications. It is essential to understand how microvesicles from pancreatic cancer act on other cells in the body. In this work, serum-derived microvesicles were isolated from 10 patients with locally advanced pancreatic cancer and healthy controls. Using Cell Transwell and WST-1 reagents, we found that microvesicles from pancreatic cancer accelerated migration and proliferation of PANC-1 cells. Meanwhile, the proliferation of these cancer-microvesicle-treated cells (CMTCs) was affected less by 10 μM of gemcitabine relative to healthy microvesicle-treated cells (HMTCs). Next, we optimized the filter-aided sample preparation method to increase the recovery of protein samples and then applied it to the quantification of the proteome of CMTCs and HMTCs. The peptides were labeled and analyzed by liquid chromatography-tandem mass spectrometry. In total, 4102 proteins were identified, where 35 proteins were up-regulated with 27 down-regulated in CMTCs. We verified the quantitative results of three key proteins CD44, PPP2R1A, and TP53 by Western blot. The Ingenuity Pathway Analysis revealed pathways that cancer microvesicles might participate in to promote cell migration and proliferation. These findings may provide novel clues of treatment for tumorigenesis and metastasis.

Indexed as

Antimetabolites, AntineoplasticCase-Control StudiesCell-Derived MicroparticlesCell Line, TumorCell MovementCell ProliferationDeoxycytidineGemcitabineGene Expression RegulationHumansHyaluronan ReceptorsPancreatic NeoplasmsProtein Phosphatase 2ProteomeTumor Suppressor Protein p53Antimetabolites, AntineoplasticCD44 protein, humanDeoxycytidineGemcitabineHyaluronan ReceptorsPPP2R1A protein, humanProtein Phosphatase 2ProteomeTP53 protein, humanTumor Suppressor Protein p53microvesiclesmigrationPANC-1 cellspancreatic cancerproliferation

Identifiers

PMID29494150
PMCPMC5915306
OpenAlexW2791016239

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.